Related Experiment Videos
Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy
1Clinical Psychopharmacology Unit, Allan Memorial Institute, Royal Victoria Hospital, Montreal, Quebec.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|November 1, 1987
Summary
Obsessive-compulsive disorder (OCD) with self-mutilation may be a distinct subgroup. Serotonergic antidepressants effectively treated two such cases, suggesting pharmacotherapy benefits for self-destructive OCD rituals.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Obsessive-compulsive disorder (OCD) is a complex mental health condition.
- Potential subgroups within OCD may respond differently to treatments.
- Self-mutilation in OCD presents unique clinical challenges.
Observation:
- Two cases of OCD involving self-mutilating behaviors were documented.
- These patients exhibited rituals manifesting as self-destructive actions.
Findings:
- Successful treatment of both cases was achieved using serotonergic antidepressants.
- This suggests a specific subgroup of OCD patients benefit from pharmacotherapy.
Implications:
- Identifies a potential treatment-responsive subgroup of OCD patients.
- Highlights the efficacy of serotonergic antidepressants for self-mutilating OCD.
- Informs clinical practice regarding pharmacotherapy for severe OCD presentations.